Global Allogeneic T Cell Therapy Market Trends
Allogeneic T-cell therapies are a form of immunotherapy that leverage T cells derived from healthy donors to treat a variety of diseases, with a primary focus on cancer. This innovative therapeutic approach begins with the collection of T cells from a compatible donor, followed by processes that may involve activation and genetic modification of these cells to enhance their anti-tumor efficacy and survival within the patient’s body.